BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cubist, Gilead, Rapidscan Pharma Solutions Inc., Astellas, Royalty Pharma sales and marketing update

Royalty Pharma acquired rights to royalties on sales of Cubicin daptomycin and Lexiscan regadenoson from an undisclosed seller for $487 million in cash. Astellas markets Lexiscan in the U.S. for use as a...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >